BREAKTHROUGH: Chloroquine phosphate -- an old anti-malaria drug -- has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Chloroquine provides both anti-viral and anti-inflammatory benefits to patients